The New England Journal of Medicine

Original Articles
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
M. L. Shiffman and Others - 12 Jul, 2007

NEJM PowerPoint Slide Set This PowerPoint Slide Set is a value added service that requires an individual subscription.

Sign In

Already a print subscriber? Activate your online access

Not a Subscriber?

Get full access to NEJM Online now with a FREE TRIAL!

Free Trial

Or, purchase full access to this
PowerPoint Slide Set for $10


Advertisement
Advertisement

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.